$AIMT Aimt has 4 important releases coming over the next 1-2 years. 1st peanut, then their egg allergen. The seafood and walnut allergen will be soon to follow in 2021. I think when the FDA approval is announced for their peanut allergen the stock is going to shoot north of $70PS, then even higher for the egg. Let’s not forget the approval that they applied for in the UK. That will also drive the price up. So in my my mind Aimmune will have 4 allergy therapies released in the U.S. and 4 released in the U.K. S a total of 8 possible FDA approvals within the next 2 years.